Using Mediational Models to Explore the Nature of Tobacco Motivation and Tobacco Treatment Effects

Journal of Abnormal Psychology

Volumn 117, Issue 1, 2008, Pages 94-105

  Piper, Megan E ^a   Federman, E Belle ^b   McCarthy, Danielle E ^c   Bolt, Daniel M ^d   Smith, Stevens S ^a   Fiore, Michael C ^a   Baker, Timothy B ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b RTI INTERNATIONAL   (United States)

^c RUTGERS UNIVERSITY   (United States)

^d UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

bupropion; mediation; smoking cessation; withdrawal

Indexed keywords

AMFEBUTAMONE; PLACEBO;

ARTICLE; CIGARETTE SMOKING; CONTROLLED STUDY; DRUG DEPENDENCE; FEMALE; HUMAN; INFORMATION PROCESSING; MAJOR CLINICAL STUDY; MALE; MEDICAL RESEARCH; MOTIVATION; PREVALENCE; SMOKING CESSATION; SURVIVAL RATE; TOBACCO DEPENDENCE;

EID: 39449085026     PISSN: 0021843X     EISSN: None     Source Type: Journal    
DOI: 10.1037/0021-843X.117.1.94     Document Type: Article

References (70)

1. Baker T.B., Morse E., and Sherman J.E. The motivation to use drugs: A psychobiological analysis of urges. In: Rivers C. (Ed). Nebraska Symposium on Motivation: Alcohol and addictive behavior 34 (1987), University of Nebraska Press, Lincoln 257-323
2. Baker T.B., Piper M.E., McCarthy D.E., Majeskie M.R., and Fiore M.C. Addiction motivation reformulated: An affective processing model of negative reinforcement. Psychological Review 111 (2004) 33-51
3. Brody A.L., Mandelkern M.A., Lee G., Smith E., Sadeghi M., Saxena S., et al. Attenuation of cue-induced cigarette craving and anterior-cingulate cortex activation in bupropion-treatment smokers: A preliminary study. Psychiatric Research 130 (2004) 269-281
4. Browne M.W., and Cudeck R. Alternative ways of assessing model fit. In: Bollen K., and Long J.S. (Eds). Testing structural equation models (1993), Sage, Newbury Park 136-162
5. Centers for Disease Control and Prevention. Cigarette smoking among adults-United States, 2000. Morbidity and Mortality Weekly Report 51 (2002) 642-645
6. Centers for Disease Control and Prevention. Cigarette smoking among adults-United States, 2002. Morbidity and Mortality Weekly Report 53 (2004) 427-431
7. Cole D.A., and Maxwell S.E. Testing mediational models with longitudinal data: Questions and tips in the use of structural equation modeling. Journal of Abnormal Psychology 112 (2003) 558-577
8. Collins L.M., Graham J.W., and Flaherty B.P. An alternative framework for defining mediation. Multivariate Behavioral Research 33 (1998) 295-312
9. Cryan J.F., Bruijnzeel A.W., Skjei K.L., and Markou A. Bupropion enhances brain reward function and reverses the affective and somatic aspects of nicotine withdrawal in the rat. Psychopharmacology 168 (2003) 347-358
10. Durcan M.J., Deener G., White J., Johnston J.A., Gonzales D., Niaura R., et al. The effect of bupropion sustained-release on cigarette craving after smoking cessation. Clinical Therapeutics 24 (2002) 540-551
11. Epping-Jordan M.P., Watkins S.S., Koob G.F., and Markou A. Dramatic decreases in brain reward function during nicotine withdrawal. Nature 393 (1998, May 7) 76-79
12. Ferguson S.G., Shiffman S., and Gwaltney C.J. Does reducing withdrawal severity mediate nicotine patch efficacy? A randomized clinical trial. Journal of Consulting and Clinical Psychology 74 (2006) 1153-1161
13. Fiore M.C., Bailey W.C., Cohen S.J., Dorfman S.F., Goldstein M.G., Gritz E.R., et al. Treating tobacco use and dependence (2000), U.S. Department of Health and Human Services, Public Health Service, Rockville, MD
14. Heatherton T.F., Kozlowski L.T., Frecker R.C., and Fagerström K.O. The Fagerström Test for Nicotine Dependence: A revision of the Fagerström Tolerance Questionnaire. British Journal of Addiction 86 (1991) 1119-1127
15. Hendricks P.S., Ditre J.W., Drobes D.J., and Brandon T.H. The early time course of smoking withdrawal effects. Psychopharmacology 187 (2006) 385-396
16. Hughes J.R., and Hatsukami D. Signs and symptoms of tobacco withdrawal. Archives of General Psychiatry 43 (1986) 289-294
17. Hughes J.R., Keely J.P., Niaura R.S., Ossip-Klein D.J., Richmond R.L., and Swan G.E. Measures of abstinence in clinical trials: Issues and recommendations. Nicotine & Tobacco Research 5 (2003) 13-25
18. Jarvik M.E., Madsen D.C., Olmstead R.E., Iwamoto-Schaap P.N., Elins J.L., and Benowitz N.L. Nicotine blood levels and subjective craving for cigarettes. Pharmacology Biochemistry and Behavior 66 (2000) 553-558
19. Jellinek E.M. The disease concept of alcoholism (1960), Hillsdale Press, New Brunswick, NJ
20. Kawakami N., Takatsuka N., Inaba S., and Shimizu H. Development of a screening questionnaire for tobacco/nicotine dependence according to ICD-10, DSM-III-R, and DSM-IV. Addictive Behaviors 24 (1999) 155-166
21. Kazdin A.E., and Nock M.K. Delineating mechanisms of change in child and adolescent therapy: Methodological issues and research recommendations. Journal of Child Psychology and Psychiatry 44 (2003) 1116-1129
22. Kenford S.L., Fiore M.C., Jorenby D.E., Smith S.S., Wetter D., and Baker T.B. Predicting smoking cessation: Who will quit with and without the nicotine patch. Journal of the American Medical Association 271 (1994) 589-594
23. Learned-Coughlin S.M., Bergstrom M., Savitcheva I., Ascher J., Schmith V.D., and Langstrom B. In vivo activity of bupropion at the human dopamine transporter as measured by positron emission tomography. Biological Psychiatry 54 (2003) 800-805
24. Lerman C., Roth D., Kaufmann V., Audrain J., Hawk L., Liu A., et al. Mediating mechanisms for the impact of bupropion in smoking cessation treatment. Drug & Alcohol Dependence 67 (2002) 219-223
25. Lindesmith A.R. Opiate addiction (1947), Principia Press, Bloomington, IN
26. Lyvers M. Drug addiction as a physical disease: The role of physical dependence and other chronic drug-induced neurophysiological changes in compulsive drug self-administration. Experimental and Clinical Psychopharmacology 6 (1998) 107-125
27. MacKinnon, D. P., Fritz, M. S., Williams, J., & Lockwood, C. M. (in press). Distribution of the product confidence limits for the indirect effect: Program PRODCLIN. Behavior Research Methods. Available from http://www.public.asu.edu/~davidpm/ripl/Prodclin
28. MacKinnon, D. P., & Lockwood, C. (2001). Distribution of products tests for the mediated effect. Unpublished manuscript.
29. MacKinnon D.P., Lockwood C.M., Hoffman J.M., West S.G., and Sheets V. A comparison of methods to test mediation and other intervening variable effects. Psychological Methods 7 (2002) 83-104
30. MacKinnon, D. P., Yoon, M., Lockwood, C. M., & Taylor, A. (2005). A comparison of methods to test mediation and other intervening variable effects in logistic regression. Manuscript submitted for publication.
31. McCarthy D.E., Bolt D.M., and Baker T.B. The importance of how: A call for mechanistic research in tobacco dependence treatment studies. In: Baker T.B., Bootzin R., and Treat T.A. (Eds). Psychological clinical science: Recent advances in theory and practice: Integrative perspectives in honor of Richard M. McFall (2007), Erlbaum, New York 133-163
32. McCarthy D.E., Piasecki T.M., Fiore M.C., and Baker T.B. Life before and after quitting smoking: An electronic diary study. Journal of Abnormal Psychology 115 (2006) 454-466
33. Mooney M.E., and Sofuoglu M. Bupropion for the treatment of nicotine withdrawal and craving. Expert Review of Neurotherapeutics 6 (2006) 965-981
34. Muthén L.K., and Muthén B.O. Mplus (Version 3) [Computer software] (2004), Author, Los Angeles
35. Newcomb M.D. Drug use and intimate relationships among women and men: Separating specific from general effects in prospective data using structural equation models. Journal of Consulting and Clinical Psychology 62 (1994) 463-476
36. Niaura R.S., Rohsenow D.J., and Binkoff J.A. Relevance of cue reactivity to understanding alcohol and smoking relapse. Journal of Abnormal Psychology 97 (1988) 133-152
37. O'Brien C.P. Experimental analysis of conditioning factors in human narcotic addiction. Pharmacological Reviews 27 (1976) 533-543
38. Piasecki T.M., Fiore M.C., McCarthy D.E., and Baker T.B. Have we lost our way? The need for dynamic formulations of relapse proneness. Addiction 97 (2002) 1093-1108
39. Piasecki T.M., Jorenby D.E., Smith S.S., Fiore M.C., and Baker T.B. Smoking withdrawal dynamics: I. Abstinence distress in lapsers and abstainers. Journal of Abnormal Psychology 112 (2003) 3-13
40. Piasecki T.M., Niaura R., Shadel W.G., Abrams D., Goldstein M., Fiore M.C., and Baker T.B. Smoking withdrawal dynamics in unaided quitters. Journal of Abnormal Psychology 109 (2000) 74-86
41. Piper, M. E., Federman, E. B., McCarthy, D. E., Bolt, D. M., Smith, S. S., Fiore, M. C., & Baker, T. B. (in press). Efficacy of bupropion alone and in combination with nicotine gum. Nicotine & Tobacco Research
42. Piper M.E., Federman E.B., Piasecki T.M., Bolt D.M., Smith S.S., Fiore M.C., and Baker T.B. A multiple motives approach to tobacco dependence: The Wisconsin Inventory of Smoking Dependence Motives (WISDM-68). Journal of Consulting and Clinical Psychology 72 (2004) 139-154
43. Radloff L.S. The CES-D scale: A self-report depression scale for research in the general population. Applied Psychological Measurement 1 (1977) 385-401
44. Raudenbush S., Bryk A., and Congdon R. HLM 5 hierarchical linear and non-linear modeling (2001), Scientific Software International, Lincolnwood, IL
45. Robinson T.E., and Berridge K.C. The neural basis of drug craving: An incentive sensitization theory of addiction. Brain Research Reviews 18 (1993) 247-291
46. Robinson T.E., and Berridge K.C. The psychology and neurobiology of addiction: An incentive-sensitization view. Addiction 8 Suppl. 2 (2000) S91-S117
47. Sayette M.A., Martin C.S., Hull J.G., Wertz J.M., and Perrott M.A. Effects of nicotine deprivation on craving response covariation in smokers. Journal of Abnormal Psychology 112 (2003) 110-118
48. Shiffman S., Ferguson S.G., Gwaltney C., Balabanais M., and Shadel W. Reduction of abstinence induced withdrawal and craving using nicotine replacement therapy. Psychopharmacology 184 (2006) 637-644
49. Shiffman S., Johnston A.J., Khayrallah M., Elash C.A., Gwaltney C.J., Paty J.A., et al. The effect of bupropion on nicotine craving and withdrawal. Psychopharmacology 148 (2000) 33-40
50. Shiffman S., and Paty J. Smoking patterns and dependence: Contrasting chippers and heavy smokers. Journal of Abnormal Psychology 115 (2006) 509-523
51. Shiffman S., Shadel W.G., Niaura R., Khayrallah M.A., Jorenby D.E., Ryan C.F., and Ferguson C.L. Efficacy of acute administration of nicotine gum in relief of cue-provoked cigarette craving. Psychopharmacology 166 (2003) 343-350
52. Shiffman S., and Waters A.J. Negative affect and smoking lapses: A prospective analysis. Journal of Consulting and Clinical Psychology 72 (2004) 192-201
53. Sobel M.E. Asymptotic confidence intervals for indirect effects for structural equation models. In: Leinhardt S. (Ed). Sociological methodology (1982), American Sociological Association, Washington, DC 290-312
54. Solomon R.L. An opponent-process theory of acquired motivation: The affective dynamics of addiction. In: Maser J.D., and Seligman M.E.P. (Eds). Psychopathology: Experimental models (1977), Freeman, San Francisco 66-103
55. Solomon R.L., and Corbit J.D. An opponent-process theory of motivation: 1. Temporal dynamics of affect. Psychological Review 81 (1974) 119-145
56. Stewart J., de Wit H., and Eikelboom R. Role of unconditioned and conditioned drug effects in the self-administration of opiates and stimulants. Psychological Review 91 (1984) 251-268
57. Stone A.A., and Shiffman S. Capturing momentary, self-report data: A proposal for reporting guidelines. Annals of Behavioral Medicine 24 (2002) 236-243
58. Stout R.L., Brown P.J., Longabaugh R., and Noel N. Determinants of research follow-up participation in an alcohol treatment outcome trial. Journal of Consulting and Clinical Psychology 64 (1996) 614-618
59. van Ree J.M., Gerrits M.A.F.M., and Vanderschuren L.J.M.J. Opioids, reward and addiction: An encounter of biology, psychology, and medicine. Pharmacological Reviews 51 (1999) 341-396
60. Warner C., and Shoaib M. How does bupropion work as a smoking cessation aid?. Addiction Biology 10 (2005) 219-231
61. Waters A.J., Shiffman S., Sayette M.A., Paty J.A., Gwaltney C.J., and Balabanis M.H. Cue-provoked craving and nicotine replacement therapy in smoking cessation. Journal of Consulting and Clinical Psychology 72 (2004) 1136-1143
62. Watkins S.S., Koob G.F., and Markou A. Neural mechanisms underlying nicotine addiction: Acute positive reinforcement and withdrawal. Nicotine & Tobacco Research 2 (2000) 19-37
63. Watson D., Clark L.A., and Tellegen A. Development and validation of brief measures of positive and negative affect: The PANAS scales. Journal of Personality and Social Psychology 54 (1988) 1063-1070
64. Welsch S.K., Smith S.S., Wetter D.W., Jorenby D.E., Fiore M.C., and Baker T.B. Development and validation of the Wisconsin Smoking Withdrawal Scale. Experimental and Clinical Psychopharmacology 7 (1999) 354-361
65. West R. Defining and assessing nicotine dependence in humans. In: Bock G., and Goode J. (Eds). Understanding nicotine and tobacco addiction (2005), Wiley, Chichester, England 36-58
66. Westman E.C., Behm F.M., Simel D.L., and Rose J.E. Smoking behavior on the first day of a quit attempt predicts long-term abstinence. Archives of Internal Medicine 157 (1997) 335-340
67. Wikler A. Recent progress in research on the neurophysiological basis of morphine addiction. American Journal of Psychiatry 105 (1948) 329-338
68. Wikler A. Opioid dependence: Mechanisms and treatment (1980), Plenum Press, New York
69. Yu C.Y., and Muthén B. Evaluation of model fit indices for latent variable models with categorical and continuous outcomes (2001) Technical report in preparation
70. Zelman D.C., Brandon T.H., Jorenby D.E., and Baker T.B. Measures of affect and nicotine dependence predict differential response to smoking cessation treatments. Journal of Consulting and Clinical Psychology 60 (1992) 943-952